The Analysis of Risk Factors and Clinical-Demographic Characteristics of Patients with Clostridium Dificille Infection as Well as The Outcome of Their Treatment

1. Moudgal V, Sobel JD. Clostridium difficile colitis: a review. Hosp Pract (1995). 2012; 40(1): 139-48.10.3810/hp.2012.02.954Search in Google Scholar

2. Furuya-Kanamori L, Stone JC, Clark J, McKenzie SJ, Yakob L et al. Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2015; 36(2): 132-41.10.1017/ice.2014.39Search in Google Scholar

3. Gao T, He B, Pan Y, Deng Q, Sun H et al. Association of Clostridium difficile infection in hospital mortality: A systematic review and meta-analysis. Am J Infect Control. 2015; 43(12): 1316-20.10.1016/j.ajic.2015.04.209Search in Google Scholar

4. Goodhand JR, Alazawi W, Rampton D. Systematic review: Clostridium difficile and inflammatory bowel disease. Aliment Pharmacol Ther. 2011; 33(4): 428-41.10.1111/j.1365-2036.2010.04548.xSearch in Google Scholar

5. Bavishi C, DuPont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Alimen Pharmacol Ther 2011; 34: 1269-81.10.1111/j.1365-2036.2011.04874.xSearch in Google Scholar

6. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012; 107(7): 1011-9.10.1038/ajg.2012.108Search in Google Scholar

7. Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012; 107: 1001-10.10.1038/ajg.2012.179Search in Google Scholar

8. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH еt al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011; 377(9759): 63-73.10.1016/S0140-6736(10)61266-4Search in Google Scholar

9. Surowiec D, Kuyumjian AG, Wynd MA, Cicogna CE. Past, present, and future therapies for Clostridium difficile-associated disease. Ann Pharmacother 2006; 40: 2155 - 63.10.1345/aph.1H33217148650Search in Google Scholar

10. Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother. 2013; 68(9): 1951-61.10.1093/jac/dkt12923620467Search in Google Scholar

11. Brown KA, Khanafer N, Daneman N, Fisman DN. Meta- analysis of antibiotics and the risk of communityassociated Clostridium difficile infection. Antimicrob Agents Chemother. 2013; 57(5): 2326-32.10.1128/AAC.02176-12363290023478961Search in Google Scholar

12. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004; 171: 33-8.10.1503/cmaj.104087643768115238493Search in Google Scholar

13. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med. 2008; 359(18): 1932-40.10.1056/NEJMra070750018971494Search in Google Scholar

14. Tang-Feldman Y, Mayo S, Silva J Jr et al. Molecular аnalysis of Clostridium difficile strains isolated from 18 cases of recurrent Clostridium difficile-associated diarrhea. J Clin Microbiology 2003; 41: 3413-4.10.1128/JCM.41.7.3413-3414.200316536912843107Search in Google Scholar

15. Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 2009; 15: 1554-80. 10.3748/wjg.15.1554266993919340897Search in Google Scholar

16. Arvand M, Hauri AM, Zaiss NH, Witte W, Bettge- Weller G. Epidemiology of severe Clostridium difficile infections in Hesse, Germany in 2008-2009. Dtsch Med Wochenschr 2010; 135(40): 1963-7.10.1055/s-0030-126334220922636Search in Google Scholar

17. Goodhand JR, Alazawi W, Rampton D. Systematic review: Clostridium difficile and inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33(4): 428-41.10.1111/j.1365-2036.2010.04548.x21198703Search in Google Scholar

18. Bajaj JS, O’Leary JG, Reddy KR, Wong F, Olson JC et al. Second infections inde-pendently increase mortality in hospitalized patients with cirrhosis: the North American сonsortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 2012; 56(6): 2328-35.10.1002/hep.25947349252822806618Search in Google Scholar

19. Di X, Bai N, Zhang X, Liu B, Ni W et al. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity. Braz J Infect Dis. 2015; 19(4):339-4910.1016/j.bjid.2015.03.00626001980Search in Google Scholar

20. Shafran DM, Shafran SD. Treating Clostridium difficile infection. CMAJ. 2014;186: 7. Search in Google Scholar